#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Squamous cell carcinoma of the hypopharynx Oesophageal squamous cell carcinoma stage III Uveitis Hereditary spastic paraplegia Mycobacterium abscessus infection Restless legs syndrome Spinal cord injury Head and neck cancer Dementia Tuberous sclerosis complex Richter's syndrome Mastocytosis Paraganglion neoplasm Antisynthetase syndrome B-cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Treatment Lysosomal storage disorder Urea cycle disorder – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Focal segmental glomerulosclerosis – Treatment Bronchiolitis obliterans syndrome – Basic Information Fabry’s disease – Basic Information Angiosarcoma metastatic Rhabdomyosarcoma recurrent Turner’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lenograstim Haloperidol Medi0618 ARTICAINE HYDROCHLORIDE Bupivacaine GSKVX000000034794 Trametinib Dimethyl Sulfoxide INCB123667 Azilsartan Medoxomil Viltolarsen Arginine D-Biotin ILOPROST AB521 Tobevibart ANX007 Nedosiran Xenon (129Xe) Iptacopan Hydrochloride Epirubicin More therapies…

    Learn about Your Condition

    Post procedural oedema Hepatic neoplasm Postpartum haemorrhage Open angle glaucoma Clinically isolated syndrome Milk allergy Choroidal dystrophy Lymphatic malformation Contusion Osteosarcoma recurrent Breast cancer stage IV Leukoencephalopathy Bartonellosis Neurodevelopmental disorder Dystonic tremor More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Aspirin for Preventing Preeclampsia in First-Time Pregnant Women Using Assisted Reproductive Technology

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pre-eclampsia
    Investigated Drugs:
    • Acetylsalicylic Acid
    France

  • Study on the Safety and Effectiveness of Semaglutide for Non-Diabetic Patients with Acute Ischemic Stroke

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Loperamide Hydrochloride
    • Acetylsalicylic Acid
    • Alteplase
    Denmark

  • Study on Preoperative Treatment with mFOLFIRINOX or Gemcitabine-Paclitaxel for Patients with Borderline Resectable Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • ANHYDROUS CALCIUM FOLINATE
    • Gemcitabine
    • Fluorouracil
    Belgium

  • Study of Incobotulinumtoxin-A Injections for Diabetic Neuropathic Pain in the Lower Limbs

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Denmark

  • Study on Edoxaban for Patients with Atrial Fibrillation and Coronary Syndrome Undergoing PCI

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic coronary syndrome
    • Acute coronary syndrome
    • Atrial fibrillation
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Prasugrel
    Belgium Denmark Italy The Netherlands

  • Study on the Safety and Effects of SQY51 for Children and Adults with Duchenne Muscular Dystrophy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Sqy51
    France
Previous Page
1 … 573 574 575 576 577 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!